Zantac / Ranitidine (NDMA Cancer) Attorney in Raleigh, North Carolina

Zantac Litigation in Raleigh / Research Triangle

Raleigh's Research Triangle Park pharmaceutical community includes major employers such as Biogen, GlaxoSmithKline (one of the Zantac defendants), Pfizer (another Zantac defendant), and numerous biotech firms. Employees and former employees of these companies with Zantac-linked cancer diagnoses have uniquely positioned claims. North Carolina's 3-year SOL is more favorable than most states. NC applies Daubert under N.C. R. Evid. 702. National counsel recommend Delaware Superior Court as primary venue. The federal Zantac MDL (No. 2924, S.D. Florida) was largely dismissed in 2022 after Judge Robin Rosenberg excluded plaintiffs' causation experts under Daubert. However, the Delaware Superior Court under Judge Vivian Medinilla continues to actively hear Zantac cases and has allowed causation experts to proceed. Defendants Sanofi, Boehringer Ingelheim, GSK, and Pfizer are all actively litigating in Delaware. For most claimants, filing in Delaware Superior Court through national plaintiffs' counsel is now the primary path forward.

Resources for Raleigh Zantac Claimants

Raleigh-area Zantac claimants should gather pharmacy records from Harris Teeter, CVS, Walgreens, and Food Lion pharmacies, as well as employer pharmacy benefit records. UNC Rex Cancer Center and WakeMed records documenting bladder, esophageal, stomach, or colorectal cancer are critical evidence. North Carolina's 3-year SOL gives claimants with 2023 or later diagnoses active filing windows — consult qualified Zantac plaintiffs' counsel promptly.